Key Drivers
- Improving Margins
- Strong Cash Flow
- Low Leverage
AIAI Summary
HSTM's upside hinges on proving its Enterprise Clinical Workforce Platform can drive measurable cross-selling and pricing power, but at ~40x earnings investors should wait for disclosed adoption and monetization evidence before underwriting a rerating, especially after dilution from the $40M equity raise.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Improving Margins
- •Strong Cash Flow
- •Low Leverage
HSTM's improving margins, free cash flow, liquidity, and low leverage support a constructive outlook, but elevated valuation, modest ROE, and heavy intangible exposure warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Modest upward bias
- •Repeated resistance
- •Neutral momentum
HSTM is cautiously bullish over the last month above $28.65–$28.90 support, but needs a sustained break above $29.77 to overcome repeated resistance and confirm upside.
Pullback from $29.65 to $29.23 reflects selling near resistance
Sentiment & News
Key News Insights:
- •Platform Expansion
- •$40M Financing
- •CEO Share Sale
HealthStream is expanding its strategic positioning while raising $40M in new capital, though the CEO's concurrent share sale warrants investor attention.
The developments are broadly supportive of growth ambitions but may prompt scrutiny of insider-selling signals
Similar Companies in Healthcare
Other companies in the same sector with AI ratings